What Really Matters?: How Insulin Dose, Timing, and Distribution Relate to Meal Composition in Free-Living People with Type 1 Diabetes
Diabetes Technology & Therapeutics · 2025
DOI: 10.1089/dia.2024.0132 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes Technology & Therapeutics, 2025. Verfasst von Elena Toschi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Joslin Diabetes Center, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Insulin, Meals, Hypoglycemic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Joslin Diabetes Center, Boston, Massachusetts, USA.
- Eli Lilly and Company, Indianapolis, Indiana, USA.
- Boston Children's Hospital, Boston, Massachusetts, USA.
- Boston Medical Center, Boston, Massachusetts, USA.
ORCID-Profile: Elena Toschi, Jie Xue
Förderung
- NIDDK NIH HHS
Zitieren
APA
Toschi, E., Edwards, S., Kao, C. Y., Xue, J., Atakov-Castillo, A., Wang, W., Steil, G., & Wolpert, H. (2025). What Really Matters?: How Insulin Dose, Timing, and Distribution Relate to Meal Composition in Free-Living People with Type 1 Diabetes. Diabetes Technology & Therapeutics. https://doi.org/10.1089/dia.2024.0132
Vancouver
Toschi E, Edwards S, Kao CY, Xue J, Atakov-Castillo A, Wang W, et al. What Really Matters?: How Insulin Dose, Timing, and Distribution Relate to Meal Composition in Free-Living People with Type 1 Diabetes. Diabetes Technology & Therapeutics. 2025. doi:10.1089/dia.2024.0132
BibTeX
@article{Toschi2025,
author = {Toschi, Elena and Edwards, Stephanie and Kao, Christi Y and Xue, Jie and Atakov-Castillo, Astrid and Wang, Wenjie and Steil, Garry and Wolpert, Howard},
title = {What Really Matters?: How Insulin Dose, Timing, and Distribution Relate to Meal Composition in Free-Living People with Type 1 Diabetes},
journal = {Diabetes Technology & Therapeutics},
year = {2025},
doi = {10.1089/dia.2024.0132}
}
EUVIMED